WIDER COPAY DIFFERENTIALS PROMOTE GENERIC DISPENSING
A new study by researchers at Express Scripts has confirmeda connection between the copay differentials forbrand and generic drugs set by drug plans and the willingnessof patients to use lower-cost generic medicines. According tothe study, plans with a generic versus brand copayment differentialof $21 or more used generic drugs at a rate 5.2%higher than those with a differential of $5 or less.
?The findings in this study show that getting plan designright pays off, given that a 1% increase in generic use resultsin an estimated 1.6% decrease in total drug-plan costs,? aspokesman for the researchers said. The study, published inthe June 2007 issue of the American Journal of Managed Care,also found that plans with $16 to $20 differentials used genericdrugs at rates that were 2.9% higher than those with thelowest differential between generic and brand copayments.
Articles in this issue
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Related Articles
- Advise Patients About Self-Care Measures to Treat Mild to Moderate GI Issues
September 18th 2025
- Evaluation of Pharmacist-Driven Penicillin Allergy Reconciliation
September 17th 2025
- Pharmacists Can Apply Their Expertise to the Medical Psilocybin Act
September 16th 2025
- From Curiosity to Clinical Impact: Shremo Msdi’s Path in Pharmacy Research
September 15th 2025